Moving ideas from prototypes to practice. And profits.
Robots that assess brain injuries. Sound waves that deliver drugs. Video games that diagnose cognitive problems.
They may sound more like sci-fi pipe dreams than practical technologies. But in fact, all three of these made-in-Ontario concepts are on the brink of implementation.
All they need is a final round of funding to bring them to market in the form of commercial devices and services that hospitals, doctors and consumers can purchase.
That’s why the Ontario Brain Institute has partnered with the federal government and with industry to create NeuroTech Ontario – an initiative that’s investing $22 million in fast-tracking the commercialization of innovative neuro-technologies.
Why the fast-track treatment? Because the sooner these devices and services get to market, the better life will be for people suffering from a number a brain-related disorders.
And there’s another important reason.
Our province is already a global leader in neuroscience research; NeuroTech Ontario will help make us players in the burgeoning global market for neuroscience products as well. As Ontario entrepreneurs build companies around new solutions like the ones profiled here, they’re also building a “neurotechnology cluster” of industries that will draw investment, and create profits, jobs and expertise. And that’s good for all of us.
Check out the “elevator pitches” on five new technologies the Ontario Brain Institute is helping to get to market.
Deep brain stimulation for Alzheimer’s disease.
Virtual reality technology for brain injury assessment.
Microparticle delivery of drugs to treat complications of cerebral hemorrhage.
An online memory health assessment tool that anyone can use.
Software-based treatment of ADD and ADHD in children.
Click here to see the other projects underway